Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): A randomized trial

Muhammad Abdulghani, C. Puckett, C. Triplitt, D. Maggs, J. Adams, E. Cersosimo, R. A. Defronzo

Research output: Contribution to journalArticlepeer-review

99 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): A randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences